Global Anatomic Pathology Market

 

 

Anatomic Pathology Market: By Product (Services (Cytopathology, Histopathology), Instruments (Slide Strainer, Tissue Processor, Microtomes), Consumables (Antibodies, Reagents)), By Application (Drug Discovery, Diagnosis), By End User (Hospitals, Research Organization, Diagnostic Centres), By Geography (Latin America, North America, Asia Pacific, The Middle East and Africa and Europe) – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Market Outline: Anatomic Pathology Market  

 

 

Anatomic Pathology is a branch of science which involves in molecular, biochemical and microscopic analysis of tissues and organs in order to find effectiveness of diseases. Main objective of anatomic pathology is identification of abnormalities to manage treatment and diagnosis. This can be helpful diagnosis of different types of cancers.

 

Market Dynamics: Anatomic Pathology Market  

 

Anatomic Pathology market is driven by growing prevalence of chronic disease, increase in geriatric population, rise in initiatives taken by the government in order to prevent the diseases. Furthermore, rise in incidence of STD’s, changes in lifestyle of people, increase in awareness regarding diseases and their preventive measures are expected to propel the growth of anatomic pathology market. On the other hand, lack of awareness in developing countries, high cost of the process are dampen the anatomic pathology market.

 

Market Scope: Anatomic Pathology Market  

 

The Anatomic Pathology Market is classified on the basis of product type, application, end user and regions.

 

Based on product type, market is segmented as

• Services
  • Cytopathology
  • Histopathology
• Instruments
  • Slide Strainer
  • Tissue Processor
  • Microtomes
• Consumables
  • Antibodies
  • Reagents

 

Based on application, market is segmented as

• Drug Discovery
• Diagnosis

 

Based on End User, market is segmented as

• Hospitals
• Research Organization
• Diagnostic Centres

 

Based on region, market is segmented as

• North America
• Latin America
• Europe
• Asia Pacific
• The Middle East and Africa

 

Regional Analysis: Anatomic Pathology Market

Geographically Anatomic Pathology Market is segmented as Latin America, Europe, Asia Pacific, North America, and The Middle East and Africa. North America is expected to remain the dominant market in global anatomic pathology market throughout the forecast period, followed by Europe due to more number of players are expected to enter into the former market during the forecast period. Japan is expected to be the next lucrative market for companies, and the market is estimated to register good revenue over the forecast period. Asia Pacific is expected to grow at fastest CAGR during the forecast period due to rising penetration of the digital imaging in emerging economies, growing investments in medical field, and the presence of untapped opportunities. Asia Pacific healthcare industry has highly influenced the anatomic pathology market due to increased incidence of cancer, geriatric population pool. Increasing demand for novel treatment options, better patient care facilities, and reduction in laboratory expenses are expected to drive demand in the coming years.

Competition Assessment

Some of the players in anatomic pathology market are

• Thermo Fisher Scientific (U.S.)
• Hoffmann-La Roche AG (Switzerland)
• Danaher Corporation (U.S.)
• Sakura Finetechnical Co., Ltd. (Japan)
• Agilent Technologies (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• NeoGenomics Laboratories, Inc. (U.S.)
• Laboratory Corporation of America Holdings (U.S.)

Key Features of the Report:

• The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

• Thermo Fisher Scientific (U.S.)
• Hoffmann-La Roche AG (Switzerland)
• Danaher Corporation (U.S.)
• Sakura Finetechnical Co., Ltd. (Japan)
• Agilent Technologies (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• NeoGenomics Laboratories, Inc. (U.S.)
• Laboratory Corporation of America Holdings (U.S.)

1. Executive Summary

 

2. Global Anatomic Pathology Market Introduction

 

2.1. Global Anatomic Pathology Market– Taxonomy

2.2. Global Anatomic Pathology Market–Definitions

2.2.1. Product Type

2.2.2. Application

2.2.3. End User

 

3. Global Anatomic Pathology Market Dynamics

 

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Anatomic Pathology Market Dynamic Factors – Impact Analysis

3.6. Global Anatomic Pathology Market– Competition Landscape

3.7. Epidemiology

 

4. Global Anatomic Pathology Market Analysis,2013 – 2017 and Forecast, 2018 – 2024

 

4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market OpportunityAnalysis

 

5. Global Anatomic Pathology Market, By Product Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

 

5.1. Services

5.1.1. Cytopathology

5.1.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.1.3. Market Opportunity Analysis

5.1.2. Histopathology

5.1.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.2.3. Market Opportunity Analysis

5.2. Instruments

5.2.1. Slide Strainer

5.2.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.1.3. Market Opportunity Analysis

5.2.2. Tissue Processor

5.2.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.2.3. Market Opportunity Analysis

5.2.3. Microtomes

5.2.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3.3. Market Opportunity Analysis

5.3. Consumables

5.3.1. Antibodies

5.3.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.1.3. Market Opportunity Analysis

5.3.2. Reagents

5.3.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.2.3. Market Opportunity Analysis

 

6. Global Anatomic Pathology Market Forecast, By Application,2013 – 2017 and Forecast, 2017 – 2024

 

6.1. Drug Discovery

6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Diagnosis

6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

 

7. Global Anatomic Pathology Market Forecast, By End User ,2013 – 2017 and Forecast, 2017 – 2024

 

7.1. Hospitals

7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Research Organization

7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Diagnostic Centres

7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

 

8. Global Anatomic Pathology Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

 

8.1. North America

8.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Europe

8.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Asia-Pacific

8.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Latin America

8.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

8.5. Middle East and Africa

8.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.5.3. Market Opportunity Analysis

8.6. Global Anatomic Pathology Market- Opportunity Analysis Index, By Product Type, By Application, By End User and Region, 2018 – 2024

 

9. North America Anatomic Pathology MarketAnalysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

 

9.1. Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)

9.1.1. Services

9.1.1.1. Cytopathology

9.1.1.2. Histopathology

9.1.2. Instruments

9.1.2.1. Slide Strainer

9.1.2.2. Tissue Processor

9.1.2.3. Microtomes

9.1.3. Consumables

9.1.3.1. Antibodies

9.1.3.2. Reagents

9.2. Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

9.2.1.1. Drug Discovery

9.2.1.2. Diagnosis

9.3.  End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

9.3.1.1. Hospitals

9.3.1.2. Research Organization

9.3.1.3. Diagnostic Centres

9.4.  Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

9.4.1. U.S.

9.4.2. Canada

9.5. North America Anatomic Pathology Market- Opportunity Analysis Index, By Product Type, By Application, By End User and Country, 2018 – 2024

9.6. North America Anatomic Pathology Market Dynamics – Trends

 

10. Europe Anatomic Pathology Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

 

10.1. Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)

10.1.1. Services

10.1.1.1. Cytopathology

10.1.1.2. Histopathology

10.1.2. Instruments

10.1.2.1. Slide Strainer

10.1.2.2. Tissue Processor

10.1.2.3. Microtomes

10.1.3. Consumables

10.1.3.1. Antibodies

10.1.3.2. Reagents

10.2. Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.2.1.1. Drug Discovery

10.2.1.2. Diagnosis

10.3.  End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.3.1.1. Hospitals

10.3.1.2. Research Organization

10.3.1.3. Diagnostic Centres

10.4. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.4.1. Germany

10.4.2. UK

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Russia

10.4.7. Poland

10.4.8. Rest of Europe

10.5. Europe Anatomic Pathology Market- Opportunity Analysis Index, By Product Type, By Application, By End User and Country,2018 – 2024

10.6. Europe Anatomic Pathology Market Dynamics – Trends

 

11. Asia-Pacific Anatomic Pathology Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

 

11.1. Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)

11.1.1. Services

11.1.1.1. Cytopathology

11.1.1.2. Histopathology

11.1.2. Instruments

11.1.2.1. Slide Strainer

11.1.2.2. Tissue Processor

11.1.2.3. Microtomes

11.1.3. Consumables

11.1.3.1. Antibodies

11.1.3.2. Reagents

11.2. Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.2.1.1. Drug Discovery

11.2.1.2. Diagnosis

11.3.  End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.3.1.1. Hospitals

11.3.1.2. Research Organization

11.3.1.3. Diagnostic Centres

11.4. Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)       

11.4.1. Japan

11.4.2. China

11.4.3. India

11.4.4. ASEAN

11.4.5. Australia & New Zealand

11.4.6. Rest of Asia-Pacific

11.5. Asia-Pacific Anatomic Pathology Market- Opportunity Analysis Index, By Product Type, By Application, By End User and Country,2018 – 2024

11.6. Asia-Pacific Anatomic Pathology Market Dynamics – Trends

 

12. Latin America Anatomic Pathology Market Analysis, 2012 – 2012 – 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

 

12.1. Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)

12.1.1. Services

12.1.1.1. Cytopathology

12.1.1.2. Histopathology

12.1.2. Instruments

12.1.2.1. Slide Strainer

12.1.2.2. Tissue Processor

12.1.2.3. Microtomes

12.1.3. Consumables

12.1.3.1. Antibodies

12.1.3.2. Reagents

12.2. Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.2.1.1. Drug Discovery

12.2.1.2. Diagnosis

12.3.  End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.3.1.1. Hospitals

12.3.1.2. Research Organization

12.3.1.3. Diagnostic Centres

12.4. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Argentina

12.4.4. Venezuela

12.4.5. Rest of Latin America

12.5. Latin America Anatomic Pathology Market- Opportunity Analysis Index, By Product Type, By Application, By End User and Country,2018 – 2024

12.6. Latin America Anatomic Pathology Market Dynamics – Trends

 

13. Middle East and Africa Anatomic Pathology Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)

 

13.1. Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)

13.1.1. Services

13.1.1.1. Cytopathology

13.1.1.2. Histopathology

13.1.2. Instruments

13.1.2.1. Slide Strainer

13.1.2.2. Tissue Processor

13.1.2.3. Microtomes

13.1.3. Consumables

13.1.3.1. Antibodies

13.1.3.2. Reagents

13.2. Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.2.1.1. Drug Discovery

13.2.1.2. Diagnosis

13.3.  End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.3.1.1. Hospitals

13.3.1.2. Research Organization

13.3.1.3. Diagnostic Centres

13.4. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

13.4.1. Gulf Cooperation Council (GCC) Countries

13.4.2. Israel

13.4.3. South Africa

13.4.4. Rest of MEA

13.5. MEA Anatomic Pathology Market- Opportunity Analysis Index, By Product Type, By Application, By End User and Country,2018 – 2024

13.6. MEA Anatomic Pathology Market Dynamics – Trends

 

14. Competition Landscape

 

14.1. Strategic Dashboard of Top Market Players

14.2. Company Profiles (Introduction, Financial Analysis, Product Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)

14.2.1.1. Thermo Fisher Scientific (U.S.)

14.2.1.2. Hoffmann-La Roche AG (Switzerland)

14.2.1.3. Danaher Corporation (U.S.)

14.2.1.4. Sakura Finetechnical Co., Ltd. (Japan)

14.2.1.5. Agilent Technologies (U.S.)

14.2.1.6. Quest Diagnostics Incorporated (U.S.)

14.2.1.7. NeoGenomics Laboratories, Inc. (U.S.)

14.2.1.8. Laboratory Corporation of America Holdings (U.S.)

 

15. Research Methodology

16. Key Assumptions and Acronyms

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

ASK AN ANALYST